281 related articles for article (PubMed ID: 12951587)
1. Mechanisms of sarcoma development.
Helman LJ; Meltzer P
Nat Rev Cancer; 2003 Sep; 3(9):685-94. PubMed ID: 12951587
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of sarcomagenesis.
Matushansky I; Maki RG
Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic testing in soft tissue sarcoma.
Antonescu CR
Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
[TBL] [Abstract][Full Text] [Related]
4. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations.
Suvà ML; Cironi L; Riggi N; Stamenkovic I
J Pathol; 2007 Oct; 213(2):117-30. PubMed ID: 17703479
[TBL] [Abstract][Full Text] [Related]
5. [Targeted treatment of rare connective tissue tumors and sarcomas].
Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in sarcomas.
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
[TBL] [Abstract][Full Text] [Related]
7. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
Riggi N; Cironi L; Suvà ML; Stamenkovic I
J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
[TBL] [Abstract][Full Text] [Related]
8. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.
Dufresne A; Brahmi M; Karanian M; Blay JY
Nat Rev Clin Oncol; 2018 Jul; 15(7):443-458. PubMed ID: 29666441
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
Todd R; Lunec J
Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology diagnosis of sarcoma].
Myklebost O
Tidsskr Nor Laegeforen; 1998 May; 118(14):2188-93. PubMed ID: 9656816
[TBL] [Abstract][Full Text] [Related]
11. The molecular pathology of sarcomas.
Powers M; Zhang W; Lopez-Terrada D; Czerniak BA; Lazar AJ
Cancer Biomark; 2010; 9(1-6):475-91. PubMed ID: 22112491
[TBL] [Abstract][Full Text] [Related]
12. Translocation-related sarcomas.
Mertens F; Antonescu CR; Hohenberger P; Ladanyi M; Modena P; D'Incalci M; Casali PG; Aglietta M; Alvegård T
Semin Oncol; 2009 Aug; 36(4):312-23. PubMed ID: 19664492
[TBL] [Abstract][Full Text] [Related]
13. Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity.
Weng WH; Lerner M; Grandér D; Ahlén J; Villablanca A; Pang ST; Wejde J; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):5-16. PubMed ID: 15586219
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia.
Joyner DE; Damron TA; Aboulafia A; Bokor W; Bastar JD; Randall RL
Tissue Antigens; 2006 Jul; 68(1):19-27. PubMed ID: 16774536
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.
Hrzenjak A; Tippl M; Kremser ML; Strohmeier B; Guelly C; Neumeister D; Lax S; Moinfar F; Tabrizi AD; Isadi-Moud N; Zatloukal K; Denk H
J Pathol; 2004 Sep; 204(1):19-27. PubMed ID: 15307134
[TBL] [Abstract][Full Text] [Related]
16. Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.
Anderson JL; Denny CT; Tap WD; Federman N
Pediatr Res; 2012 Aug; 72(2):112-21. PubMed ID: 22546864
[TBL] [Abstract][Full Text] [Related]
17. [Targeted therapy of sarcomas].
Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
[TBL] [Abstract][Full Text] [Related]
18. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
Hogendoorn PC; Collin F; Daugaard S; Dei Tos AP; Fisher C; Schneider U; Sciot R;
Eur J Cancer; 2004 Jul; 40(11):1644-54. PubMed ID: 15251152
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor system and sarcomas.
Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT
J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression signature of human sarcomas.
Subramanian S; Lui WO; Lee CH; Espinosa I; Nielsen TO; Heinrich MC; Corless CL; Fire AZ; van de Rijn M
Oncogene; 2008 Mar; 27(14):2015-26. PubMed ID: 17922033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
